Candelaria Hernández, Myrna, Xavier López Karpovitch, Francisco Javier Mijangos, Efreen Montaño, Arely Lemus Carmona, Silvia Guzmán Vázquez, and Herman Soto Molina. “Cost-Effectiveness of Azacitidine Compared With Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS)”. Global and Regional Health Technology Assessment 4, no. 1 (May 31, 2017): 114–121. Accessed July 22, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/385.